BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33289586)

  • 21. [Role of histone deacetylase in inhibiting invasion of human gastric carcinoma cell line SGC-7901 by PPARgamma-mediated pathway].
    Ma GD; Zhang CQ; Hou J; Zhang LY; Lin C
    Ai Zheng; 2009 Jul; 28(7):695-701. PubMed ID: 19624894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
    Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
    Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The osteogenic differentiation of human adipose-derived stem cells is regulated through the let-7i-3p/LEF1/β-catenin axis under cyclic strain.
    Luo Y; Ge R; Wu H; Ding X; Song H; Ji H; Li M; Ma Y; Li S; Wang C; Du H
    Stem Cell Res Ther; 2019 Nov; 10(1):339. PubMed ID: 31753039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.
    Bleckmann A; Siam L; Klemm F; Rietkötter E; Wegner C; Kramer F; Beissbarth T; Binder C; Stadelmann C; Pukrop T
    Clin Exp Metastasis; 2013 Apr; 30(4):471-82. PubMed ID: 23224985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
    Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
    Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The protective effect of PPARγ in sepsis-induced acute lung injury via inhibiting PTEN/β-catenin pathway.
    Liu L; Chen J; Zhang X; Cui X; Qiao N; Zhang Y; Yang J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32420586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPAR(gamma)/PGC-1(alpha) pathway in E-cadherin expression and motility of HepG2 cells.
    Lee HJ; Su Y; Yin PH; Lee HC; Chi CW
    Anticancer Res; 2009 Dec; 29(12):5057-63. PubMed ID: 20044617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canonical Notch signalling is inactive in urothelial carcinoma.
    Greife A; Jankowiak S; Steinbring J; Nikpour P; Niegisch G; Hoffmann MJ; Schulz WA
    BMC Cancer; 2014 Aug; 14():628. PubMed ID: 25167871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.
    Cheng S; Qian K; Wang Y; Wang G; Liu X; Xiao Y; Wang X
    J Cell Mol Med; 2019 May; 23(5):3724-3736. PubMed ID: 30912275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.
    Wang Z; Yang S; Li Y; Zhou Y; Liu D; Liu J; DiSanto ME; Zhang X
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
    Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
    J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.
    Wu CF; Ng KF; Chen CS; Chang PL; Chuang CK; Weng WH; Liao SK; Pang ST
    Br J Cancer; 2010 Sep; 103(6):852-60. PubMed ID: 20736946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1.
    Chan SC; Hajarnis SS; Vrba SM; Patel V; Igarashi P
    J Biol Chem; 2020 Dec; 295(51):17560-17572. PubMed ID: 33453998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.
    Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y
    Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690
    [No Abstract]   [Full Text] [Related]  

  • 36. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
    Dong YW; Wang XP; Wu K
    World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.
    Pang X; Wei Y; Zhang Y; Zhang M; Lu Y; Shen P
    Cancer Sci; 2013 Jun; 104(6):672-80. PubMed ID: 23461356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.